LIACX
Price
$11.58
Change
-$0.07 (-0.60%)
Updated
Sep 20 closing price
RPTIX
Price
$109.40
Change
-$0.77 (-0.70%)
Updated
Sep 20 closing price
Ad is loading...

LIACX vs RPTIX

Header iconLIACX vs RPTIX Comparison
Open Charts LIACX vs RPTIXBanner chart's image
Columbia Acorn C
Price$11.58
Change-$0.07 (-0.60%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Mid-Cap Growth I
Price$109.40
Change-$0.77 (-0.70%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
LIACX vs RPTIX Comparison Chart
Loading...
VS
LIACX vs. RPTIX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIACX is a Buy and RPTIX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RPTIX has more cash in the bank: 31.4B vs. LIACX (2.82B). RPTIX pays higher dividends than LIACX: RPTIX (0.18) vs LIACX (0.00). LIACX was incepted earlier than RPTIX: LIACX (24 years) vs RPTIX (9 years). LIACX is a more actively managed with annual turnover of: 64.00 vs. RPTIX (21.70). LIACX has a lower initial minimum investment than RPTIX: LIACX (2000) vs RPTIX (500000). LIACX annual gain was more profitable for investors over the last year : 23.85 vs. RPTIX (14.81). RPTIX return over 5 years is better than : 15.09 vs. LIACX (-39.94).
LIACXRPTIXLIACX / RPTIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years9 years-
Gain YTD11.4539.127125%
Front LoadN/AN/A-
Min. Initial Investment20005000000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.82B31.4B9%
Annual Yield % from dividends0.000.18-
Returns for 1 year23.8514.81161%
Returns for 3 years-30.79-13.57227%
Returns for 5 years-39.9415.09-265%
Returns for 10 years-90.28N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLH246.88-0.54
-0.22%
Clean Harbors
TOI0.29N/A
-0.58%
Oncology Institute (The)
CINT6.59-0.04
-0.60%
CI&T
CSTM16.22-0.54
-3.22%
Constellium SE
KTTA4.43-0.37
-7.71%
Pasithea Therapeutics Corp